Bruce Gil

Collectively, the largest healthcare companies in America generated $2.4 trillion in revenue in the four most recent quarters

CagriSema, Novo Nordisk's planned Ozempic successor, failed to meet analysts' expectation in a clinical trial

Early trials show that Eli Lilly's experimental pill, orforglipron, could result in about the same amount of weight loss as Wegovy

Plus, Pfizer considers moving more production to the US and obesity is on the rise worldwide

Elon Musk's estimated net worth has plunged, falling from a peak of $486 billion to $330 billion

Novo Nordisk CEO Lars Fruergaard Jorgensen said the company, which makes Ozempic and Wegovy, is not 'immune' to tariffs

Uninsured patients or those with insurance that doesn't cover obesity treatments can now get Novo Nordisk's weight loss drug for $499 a month

Amgen just got one step closer to bringing its monthly weight loss drug to market

A new study found that about 57% of men and 60% of women could be overweight or obese by 2050

Eli Lilly launched a new ad campaign warning consumers about off-brand versions of its drugs